Ticker
DSGNCompany Name
DESIGN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 226.08M | $ 648K | $ 0 | $ 0 | -0.29% |
3/31/2025 | $ 189.04M | $ 516K | $ 0 | $ 0 | -0.27% |
12/31/2024 | $ 276.43M | $ 513K | $ 0 | $ 0 | -0.19% |
9/30/2024 | $ 327.84M | $ 751K | $ 0 | $ 0 | -0.23% |
6/30/2024 | $ 263.85M | $ 763K | $ 0 | $ 0 | -0.29% |
3/31/2024 | $ 264.96M | $ 744K | $ 0 | $ 0 | -0.28% |
12/31/2023 | $ 146.32M | $ 724K | $ 0 | $ 0 | -0.49% |
9/30/2023 | $ 114.8M | $ 353K | $ 0 | $ 0 | -0.31% |
6/30/2023 | $ 410.38M | $ 491K | $ 0 | $ 0 | -0.12% |
3/31/2023 | $ 422.39M | $ 506K | $ 0 | $ 0 | -0.12% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for DESIGN THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 1K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -200K ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.49K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |